![]() |
|
|||||||
| Register | FAQ | Calendar | Today's Posts | Search |
![]() |
|
|
Thread Tools | Search this Thread | Display Modes |
|
#1
|
|||
|
|||
|
Regulatory hurdles and supply chain issues could slow efforts to produce generic versions of Merck’s antiviral molnupiravir for developing nations, despite licensing agreements.
More... |